Upgrade to SI Premium - Free Trial

IBM (IBM) Not Immune to Macro Headwinds- UBS

September 28, 2022 2:05 PM
UBS cut IBM's price target to $112 from $118 on Wednesday, maintaining a Sell rating on the stock, stating the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change Hot List

Next Articles